0 Comentários
0 Compartilhamentos
954 Visualizações
0 Anterior
Pesquisar
Conheça novas pessoas, crie conexões e faça novos amigos
-
Faça o login para curtir, compartilhar e comentar!
-
Immuno Oncology Assays Market: Insights and Competitive AnalysisExecutive Summary Immuno Oncology Assays Market Size and Share Across Top Segments CAGR Value The global immuno oncology assays market size was valued at USD 6.80 billion in 2025 and is expected to reach USD 16.45 billion by 2033, at a CAGR of 11.68% during the forecast period To better structure this Immuno Oncology Assays report, a nice blend of...0 Comentários 0 Compartilhamentos 1KB Visualizações 0 Anterior
-
Late-Stage Oncology Drug Pipeline Market Share and Size Report: Emerging Trends and Forecast Analysis" According to the latest report published by Data Bridge Market Research, the Late-Stage Oncology Drug Pipeline Market The global late-stage oncology drug pipeline market size was valued at USD 10.85 billion in 2025 and is expected to reach USD 26.67 billion by 2033, at a CAGR of 11.90% during the forecast period A large scale Late-Stage Oncology Drug...0 Comentários 0 Compartilhamentos 131 Visualizações 0 Anterior
-
Long-Acting Injectable Oncology Drug Market Size Forecast and Segment AnalysisAccording to the latest report published by Data Bridge Market Research, the Long-Acting Injectable Oncology Drug Market The global long-acting injectable oncology drug market size was valued at USD 7.16 billion in 2025 and is expected to reach USD 17.60 billion by 2033, at a CAGR of 11.90% during the forecast period Quality and transparency has been strictly maintained while carrying...0 Comentários 0 Compartilhamentos 26 Visualizações 0 Anterior
-
Oral Targeted Oncology Drug Market Report: Growth Analysis, Trends & Future Outlook"Executive Summary Oral Targeted Oncology Drug Market Market: Growth Trends and Share Breakdown The global oral targeted oncology drug market size was valued at USD 20.73 billion in 2025 and is expected to reach USD 43.47 billion by 2033, at a CAGR of 9.70% during the forecast period In this competitive marketplace, businesses are always in struggle to seek...0 Comentários 0 Compartilhamentos 1KB Visualizações 0 Anterior
-
Precision Oncology Drug Portfolio Market Size, Industry Development and Forecast Insights"Executive Summary Precision Oncology Drug Portfolio Market Market: Share, Size & Strategic Insights The global precision oncology drug portfolio market size was valued at USD 18.76 billion in 2025 and is expected to reach USD 45.46 billion by 2033, at a CAGR of 11.70% during the forecast period This Precision Oncology Drug Portfolio Market Market research...0 Comentários 0 Compartilhamentos 1KB Visualizações 0 Anterior
-
Precision Oncology Drug Portfolio market Forecast: Trends, Demand & Revenue Analysis"Precision Oncology Drug Portfolio Market Summary: According to the latest report published by Data Bridge Market Research, the Precision Oncology Drug Portfolio Market The global precision oncology drug portfolio market size was valued at USD 18.76 billion in 2025 and is expected to reach USD 45.46 billion by 2033, at a CAGR of 11.70% during the forecast...0 Comentários 0 Compartilhamentos 617 Visualizações 0 Anterior
-
Precision Oncology Drug Portfolio market Forecast: Trends, Demand & Revenue Analysis"Precision Oncology Drug Portfolio Market Summary: According to the latest report published by Data Bridge Market Research, the Precision Oncology Drug Portfolio Market The global precision oncology drug portfolio market size was valued at USD 18.76 billion in 2025 and is expected to reach USD 45.46 billion by 2033, at a CAGR of 11.70% during the forecast...0 Comentários 0 Compartilhamentos 586 Visualizações 0 Anterior
-
7 Breakthroughs in Oncology Decision Support Software for 2026Cognitive Computing in Cancer Information Management Software The year 2026 marks a turning point where oncology decision support software has fully integrated cognitive computing to assist multidisciplinary tumor boards. These systems analyze vast amounts of literature and clinical trial data to provide real-time recommendations for complex cases. Cancer information management software now...0 Comentários 0 Compartilhamentos 1KB Visualizações 0 Anterior
-
7 oncology navigation protocols entering US clinics in 2026Cancer care in 2026 has transitioned from a standardized "treatment by stage" approach to a hyper-individualized molecular navigation paradigm. The National Cancer Institute (NCI) has recently launched the "Onco-Navigator" pilot, which integrates genomic sequencing, lifestyle data, and real-time response monitoring into a single dashboard. This allows oncologists to adjust chemotherapy or...0 Comentários 0 Compartilhamentos 1KB Visualizações 0 Anterior
-
Acalabrutinib Market Research Highlights Innovation in Modern Oncology SolutionsAcalabrutinib Market Research Highlights Innovation in Modern Oncology Solutions The Acalabrutinib Market research emphasizes the growing role of innovative therapies in reshaping global oncology treatment standards. The healthcare industry is increasingly adopting targeted medicines designed to improve treatment outcomes while reducing unwanted side effects. Acalabrutinib has gained...0 Comentários 0 Compartilhamentos 553 Visualizações 0 Anterior
-
Accelerating Momentum: Factors Driving Oncology Device Market GrowthThe continuous Oncology Device Market growth is a testament to the effectiveness of new treatment modalities and the rising awareness about early cancer detection. Major accelerators include the establishment of specialized cancer hospitals and clinics, which require state-of-the-art equipment for comprehensive patient care. This systematic infrastructure development globally is a...0 Comentários 0 Compartilhamentos 2KB Visualizações 0 Anterior
-
Advancements in Biopharmaceuticals Accelerate the Global EPO Drugs MarketGlobal Demand Outlook for Executive Summary Erythropoietin (EPO) Drugs Market Size and Share CAGR Value Global Erythropoietin (EPO) Drugs Market report is a highly visual business report where the key market research findings have been organized, analyzed, and summarized neatly. This report can be communicated more effectively with a team, stakeholders, and customers. With devotion,...0 Comentários 0 Compartilhamentos 1KB Visualizações 0 Anterior
-
Are HER2 Inhibitors Transforming Targeted Therapy in Oncology Treatment?Executive Summary HER2 Inhibitors Market: Share, Size & Strategic Insights CAGR Value The global HER2 inhibitors market size was valued at USD 11.05 billion in 2025 and is expected to reach USD 22.02 billion by 2033, at a CAGR of 9.00% during the forecast period HER2 Inhibitors Market research report works best for the systematic gathering,...0 Comentários 0 Compartilhamentos 3KB Visualizações 0 Anterior
-
Are Immune-Modulating Biologics Redefining the Future of Cancer Immunotherapy?Executive Summary Immune-Modulating Oncology Biologic Drugs Market Size and Share: Global Industry Snapshot CAGR Value The global immune-modulating oncology biologic drugs market size was valued at USD 10.10 billion in 2025 and is expected to reach USD 28.54 billion by 2033, at a CAGR of13.87% during the forecast period The research and analysis...0 Comentários 0 Compartilhamentos 2KB Visualizações 0 Anterior
-
Are Medical Cyclotrons Advancing Precision in Cancer Diagnosis and Treatment?Regional Overview of Executive Summary Medical Cyclotron Market by Size and Share CAGR Value The global medical cyclotron market size was valued at USD 228.20 million in 2025 and is expected to reach USD 466.85 million by 2033, at a CAGR of 9.36% during the forecast period The market report also contains the drivers and restraints for the Medical...0 Comentários 0 Compartilhamentos 2KB Visualizações 0 Anterior
-
Are Neoantigen Cancer Vaccines the Next Breakthrough in Personalized Oncology?Executive Summary Neoantigen Cancer Vaccine Therapy Market Market Size and Share Forecast CAGR Value The global neoantigen cancer vaccine therapy market size was valued at USD 986 Million in 2025 and is expected to reach USD 6547.71 Million by 2033, at a CAGR of 26.70% during the forecast period The comprehensive market information and data of...0 Comentários 0 Compartilhamentos 2KB Visualizações 0 Anterior
-
Are Personalized Cancer Vaccines the Future of Oncology Treatment?Latest Insights on Executive Summary Personalized Cancer Vaccines Market Share and Size CAGR Value Data Bridge Market Research analyses that the global personalized cancer vaccines market which was USD 2,34,790.00 million in 2022, is expected to reach USD 3,71,404.60 million by 2030, and is expected to undergo a CAGR of 5.9% during the forecast period of 2023 to 2030. The market...0 Comentários 0 Compartilhamentos 3KB Visualizações 0 Anterior
Páginas impulsionada
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Greek